American Portfolios Advisors Hepion Pharmaceuticals, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Mar 24, 2023
BUY
$2.25 - $6.99 $4,500 - $13,980
2,000 New
2,000 $10.7 Million

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $45.7M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email